These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19700060)

  • 1. Stroke in ESRD: the other cardiovascular disease.
    Seliger SL
    Am J Kidney Dis; 2009 Sep; 54(3):403-5. PubMed ID: 19700060
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular problems in ESRD patients.
    Lameire N
    Nefrologia; 2000; 20 Suppl 3():33-40. PubMed ID: 10835875
    [No Abstract]   [Full Text] [Related]  

  • 3. Choice of ESRD treatment strategy according to cardiac status.
    Wizemann V; Kramer W
    Kidney Int Suppl; 1988 Mar; 24():S191-5. PubMed ID: 3283409
    [No Abstract]   [Full Text] [Related]  

  • 4. [The kidneys and the heart].
    Mann J; Hilgers KF; Veelken R; Kunz R
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1839-43. PubMed ID: 18770484
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond Framingham: cardiovascular risk profiling in ESRD.
    McClellan WM; Chertow GM
    J Am Soc Nephrol; 2005 Jun; 16(6):1539-41. PubMed ID: 15872082
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy for cardiovascular disease in dialysis patients.
    Ring T
    Kidney Int; 2000 Feb; 57(2):740-1. PubMed ID: 10712120
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction: the reverse epidemiology controversy.
    Kovesdy CP; Kalantar-Zadeh K
    Semin Dial; 2007; 20(6):485. PubMed ID: 17991191
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal Association Clinical Practice Guideline on cardiovascular disease in CKD.
    Holt S; Goldsmith D
    Nephron Clin Pract; 2011; 118 Suppl 1():c125-44. PubMed ID: 21555891
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing cardiovascular disease in the dialysis patient.
    Baig SZ; Coats WC; Aggarwal KB; Alpert MA
    Adv Perit Dial; 2009; 25():147-54. PubMed ID: 19886337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney in the pathophysiology and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2001; 3(3):139. PubMed ID: 11975782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular diseases and modern prospects for preventing stroke].
    Eliseev OM; Oshchepkova EV
    Ter Arkh; 2002; 74(9):73-8. PubMed ID: 12418127
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein intake and chronic kidney disease: literature review, 2003 to 2008.
    Aparicio M
    J Ren Nutr; 2009 Sep; 19(5 Suppl):S5-8. PubMed ID: 19712877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiorenal anemic syndrome: clinical significance and therapeutic principles].
    Kozlovskaia LV; Milovanov IuS; Fomin VV; Milovanova LIu
    Ter Arkh; 2005; 77(6):82-7. PubMed ID: 16078609
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients.
    Meier P; Blanc E
    Kidney Int; 2003 Oct; 64(4):1532-3. PubMed ID: 12969179
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic kidney disease: a new opportunity for better cardiovascular risk stratification.
    Hallan SI
    J Intern Med; 2009 Oct; 266(4):414-7. PubMed ID: 19765183
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer of hormone-dependent tissues and problems of comorbidity (cardiovascular diseases, stroke, osteoporosis)].
    Bershteĭn LM
    Vopr Onkol; 2010; 56(4):384-92. PubMed ID: 20968013
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving a nation's cardiac health. Interview by Judy Ozkan, BA.
    Burns H
    Circulation; 2006 Apr; 113(13):f50-1. PubMed ID: 16596719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipids disorders in chronic kidney disease].
    Rozentryt P; Poloński L
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II69-75. PubMed ID: 19813340
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.